Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wiman

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|December 19, 1985
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarctionA Hamsten, B Wiman, U de Faire, et al.
Thrombosis Research|January 1, 1979
A coagulo-radioimmunometric assay for the quantitation of fibrin monomer in human plasma. Principles and development of the methodJ Félez, E F Plow, B Wiman, et al.
Thrombosis Research|August 1, 1978
Effects of the synthetic fibrinolytic agents ortho-thymotic acid and S-1623 on the reaction between human plasmin and antiplasminM H Prandini, B Wiman, M Samama, et al.
Arteriosclerosis (Dallas, Tex.)|November 1, 1990
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoproteinA Stiko-Rahm, B Wiman, A Hamsten, et al.
Diabetologia|September 1, 1993
Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic menA Asplund-Carlson, A Hamsten, B Wiman, et al.
Journal of Internal Medicine|October 1, 1994
Pathophysiology of fibrinolysisP J Declerck, I Juhan-Vague, J Felez, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|January 1, 1991
Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activityS Dawson, A Hamsten, B Wiman, et al.
Thrombosis Research|September 1, 1985
Modification of a tyrosine residue in the carboxyterminal portion of human alpha2-antiplasminH R Lijnen, B Van Hoef, B Wiman, et al.
Thrombosis and Haemostasis|June 30, 1986
Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serumG Urdén, U Johansson, J Chmielewska, et al.
Thrombosis Research|July 1, 1982
Purification and partial primary structure of cyanogen bromide fragments from human alpha 2-antiplasminH R Lijnen, B Wiman, B van Hoef, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|December 19, 1985
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarctionA Hamsten, B Wiman, U de Faire, et al.
Thrombosis Research|January 1, 1979
A coagulo-radioimmunometric assay for the quantitation of fibrin monomer in human plasma. Principles and development of the methodJ Félez, E F Plow, B Wiman, et al.
Thrombosis Research|August 1, 1978
Effects of the synthetic fibrinolytic agents ortho-thymotic acid and S-1623 on the reaction between human plasmin and antiplasminM H Prandini, B Wiman, M Samama, et al.
Arteriosclerosis (Dallas, Tex.)|November 1, 1990
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoproteinA Stiko-Rahm, B Wiman, A Hamsten, et al.
Diabetologia|September 1, 1993
Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic menA Asplund-Carlson, A Hamsten, B Wiman, et al.
Journal of Internal Medicine|October 1, 1994
Pathophysiology of fibrinolysisP J Declerck, I Juhan-Vague, J Felez, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|January 1, 1991
Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activityS Dawson, A Hamsten, B Wiman, et al.
Thrombosis Research|September 1, 1985
Modification of a tyrosine residue in the carboxyterminal portion of human alpha2-antiplasminH R Lijnen, B Van Hoef, B Wiman, et al.
Thrombosis and Haemostasis|June 30, 1986
Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serumG Urdén, U Johansson, J Chmielewska, et al.
Thrombosis Research|July 1, 1982
Purification and partial primary structure of cyanogen bromide fragments from human alpha 2-antiplasminH R Lijnen, B Wiman, B van Hoef, et al.
Pageof 13